For pharma brands, AI visibility is no longer just a digital question, it is fast becoming a brand strategy imperative ...

UK market access needs the right conditions nationally, along with subnational investment and delivery locally ...

The National Institute for Health and Care Excellence (NICE) has recommended Genmab UK’s Tivdak (tisotumab vedotin) for ...

The “problem” in healthcare comms is rarely what you say, it’s whether people can act on it. This article explains how we ...

In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin ...

Eli Lilly is to acquire LimmaTech Biologics and Vaccine Company. Along with its acquisition of Curevo, the companies will ...

This year, we welcome Simon Bates as the new Chair of the judging panel, someone who has been a judge and steering group ...

Engaging healthcare professionals (HCPs) remains a persistent challenge for pharmaceutical companies, not because of a lack ...

Over the last decade, the trial landscape has been undergoing reforms to become more focused on enrolling a diverse ...

Moderna has appointed Piyali Mukherjee as Head of Medical Affairs, Europe and Middle East. She will be based in Switzerland ...

How often do patient insights actually change what an organisation does next? If your answer is ‘hard to know’ then that’s a ...

GenAI now sits between us and our audience. The problem isn’t hallucinations While hallucinations dominate discussions, the ...